Method for increasing the E-selectin binding affinity of a population of cells expressing a CD44 polypeptide
US9523078B2 · kind B2 · utility
2Cited by
8References
16Claims
0Family size
Inventor
Key dates
| Filing date | Jun 21, 2012 |
| Grant date | Dec 20, 2016 |
| Priority date | — |
| Expiry date | Dec 22, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2501/90
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention features methods and compositions for treating hematopoietic disorders, inflammatory conditions, and cancer and providing stem cell therapy in a mammal.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.